Summary - A new market study, titled “ Global Cell Therapy and Tissue Engineering Market Size, Status and Forecast 2019-2025”…December 09, 2020

Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.

Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.

In 2018, the global Cell Therapy and Tissue Engineering market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cell Therapy and Tissue Engineering status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Therapy and Tissue Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Betalin Therapeutics

BioCardia, Inc

BioReliance Corporation

Biosolution Co., Ltd.

Brainstorm Cell Therapeutics, Inc

MaxCyte, Inc

Medigene AG

MEDIPOST CO., Ltd.

Mesoblast Limited

Miromatrix Medical, Inc.

MolMed S.p.A

Mustang Bio, Inc

NantKwest, Inc.

Neuralstem, Inc

NexImmune, Inc.

Nohla Therapeutics, Inc

ReNeuron Group plc

Richter-Helm BioLogics GmbH & Co. KG

RoosterBio, Inc

RoslinCT

Rubius Therapeutics, Inc.

Sangamo Therapeutics, Inc

Voyager Therapeutics, Inc

Waisman Biomanufacturing

WindMIL Therapeutics, Inc.

Wuxi App Tec, Inc.

ReNeuron Group plc

Richter-Helm BioLogics GmbH & Co. KG

RoosterBio, Inc

RoslinCT

ALSO READ : http://www.marketwatch.com/story/global-cell-therapy-and-tissue-eng...

Market segment by Type, the product can be split into

Cell Therapy

Tissue Engineering

Market segment by Application, split into

Cell Defects

Genetic Diseases

Neurodegenerative Diseases

Tissue Malignancies

Others

Market segment by Regions/Countries, this report covers

North America

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Cell Therapy and Tissue Engineering status, future forecast, growth opportunity, key market and key players.

To present the Cell Therapy and Tissue Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cell Therapy and Tissue Engineering are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

FOR MORE DETAILS https://www.wiseguyreports.com/reports/4202226-global-cell-therapy-...

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Us:

NORAH TRENT

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)